Is Zepbound being removed from the FDA shortage list? The latest availability updates
•
3 min read
In December 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order confirming that the national shortage of tirzepatide, the active ingredient in Zepbound and Mounjaro, had been resolved. This definitive action provided a clear answer to the question, **Is Zepbound being removed from the FDA shortage list?**, and marked a major turning point for patient access and drug availability.
